MFDS — authorised 19 January 2021
- Marketing authorisation holder: MERCK SHARP DOHME
- Status: likely_approved
🇰🇷 Verquvo in South Korea
MFDS authorised Verquvo on 19 January 2021
Marketing authorisation
Verquvo in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in South Korea
Frequently asked questions
Is Verquvo approved in South Korea?
Yes. MFDS authorised it on 19 January 2021.
Who is the marketing authorisation holder for Verquvo in South Korea?
MERCK SHARP DOHME holds the South Korean marketing authorisation.